AptarGroup stock heads into October 29 earnings after Q2 growth

Published on 10/07/2026 at 01:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AptarGroup stock posted Q2 revenue of USD 1.03 billion, up 6.3 percent year over year, on July 30. Adjusted EPS fell 15 percent to USD 1.42.

ATR, US0383361039, Illustration mit AI erstellt.

AptarGroup stock (ISIN US0383361039) was trading at USD 120.75 on the NYSE on October 6, 2026, up 0.12 percent at 2:36 p.m. ET. The next scheduled company checkpoint is the Q3 2026 earnings release on October 29, putting the recent margin and earnings trend at the center of the setup.

Q2 revenue reached a record

According to MarketBeat, AptarGroup reported USD 1.03 billion in Q2 2026 revenue, an increase of 6.3 percent from the prior year. Adjusted EPS came in at USD 1.42, above the USD 1.35 consensus estimate but below the USD 1.66 recorded in the comparable quarter.

The earnings beat therefore came with a mixed operating signal. Revenue growth was positive, but adjusted EPS declined 15 percent year over year, making margin execution more important than the top-line milestone ahead of the October report.

Pharma growth faces margin pressure

The Q2 2026 earnings-call transcript published by Yahoo Finance says adjusted EBITDA was USD 213 million, down 3 percent year over year, while adjusted EBITDA margin fell to 20.7 percent from 22.6 percent. The same transcript reports prescription growth of 8 percent, injectable growth of 9 percent and consumer healthcare growth of 15 percent in Q2, excluding emergency medicine destocking.

The company guided to Q3 2026 adjusted EPS of USD 1.45 to USD 1.53 in the same earnings-call material. That range sits above the Q2 adjusted EPS result of USD 1.42, so the October release will show whether the expected improvement is reaching consolidated earnings rather than remaining concentrated in Pharma.

Consensus target stays well above price

MarketBeat reports a Moderate Buy consensus from eight analysts, including five Buy ratings and three Holds. The average target is USD 172.80, with a high of USD 220.00 and a low of USD 155.00; at the October 6 price of USD 120.75, the stock lies 30.1 percent below the average target.

That gap is a valuation signal, not a forecast guarantee. The consensus is set against a stock that remains below its 52-week high of USD 146.91 and above its 52-week low of USD 103.23, while the October 29 report provides the next objective test of the earnings recovery.

October 29 is the next test

AptarGroup stock was last at USD 120.75 on the NYSE on October 6, 2026, at 2:36 p.m. ET. The session range was USD 118.86 to USD 121.13, and market capitalization stood at USD 7.7 billion.